Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 109

1.

Focus on Formononetin: Anticancer Potential and Molecular Targets.

Ong SKL, Shanmugam MK, Fan L, Fraser SE, Arfuso F, Ahn KS, Sethi G, Bishayee A.

Cancers (Basel). 2019 May 1;11(5). pii: E611. doi: 10.3390/cancers11050611. Review.

2.

Honokiol for cancer therapeutics: A traditional medicine that can modulate multiple oncogenic targets.

Banik K, Ranaware AM, Deshpande V, Nalawade SP, Padmavathi G, Bordoloi D, Sailo BL, Shanmugam MK, Fan L, Arfuso F, Sethi G, Kunnumakkara AB.

Pharmacol Res. 2019 Jun;144:192-209. doi: 10.1016/j.phrs.2019.04.004. Epub 2019 Apr 17. Review.

PMID:
31002949
3.

An in vivo pharmacological study: Variation in tissue-accumulation for the drug probucol as the result of targeted microtechnology and matrix-acrylic acid optimization and stabilization techniques.

Mooranian A, Zamani N, Takechi R, Luna G, Mikov M, Goločorbin-Kon S, Elnashar M, Arfuso F, Al-Salami H.

PLoS One. 2019 Apr 4;14(4):e0214984. doi: 10.1371/journal.pone.0214984. eCollection 2019.

4.

Role of Natural Products in Modulating Histone Deacetylases in Cancer.

Merarchi M, Sethi G, Shanmugam MK, Fan L, Arfuso F, Ahn KS.

Molecules. 2019 Mar 16;24(6). pii: E1047. doi: 10.3390/molecules24061047. Review.

5.

Potential of Zerumbone as an Anti-Cancer Agent.

Girisa S, Shabnam B, Monisha J, Fan L, Halim CE, Arfuso F, Ahn KS, Sethi G, Kunnumakkara AB.

Molecules. 2019 Feb 18;24(4). pii: E734. doi: 10.3390/molecules24040734. Review.

6.

Encapsulated human mesenchymal stem cells (eMSCs) as a novel anti-cancer agent targeting breast cancer stem cells: Development of 3D primed therapeutic MSCs.

Mandal S, Arfuso F, Sethi G, Dharmarajan A, Warrier S.

Int J Biochem Cell Biol. 2019 May;110:59-69. doi: 10.1016/j.biocel.2019.02.001. Epub 2019 Feb 6.

PMID:
30735730
7.

Stability and biological testing of taurine-conjugated bile acid antioxidant microcapsules for diabetes treatment.

Mooranian A, Zamani N, Mikov M, Goločorbin-Kon S, Stojanovic G, Arfuso F, Al-Salami H.

Ther Deliv. 2019 Feb;10(2):99-106. doi: 10.4155/tde-2018-0034.

PMID:
30729887
8.

Epigenetic demethylation of sFRPs, with emphasis on sFRP4 activation, leading to Wnt signalling suppression and histone modifications in breast, prostate, and ovary cancer stem cells.

Deshmukh A, Arfuso F, Newsholme P, Dharmarajan A.

Int J Biochem Cell Biol. 2019 Apr;109:23-32. doi: 10.1016/j.biocel.2019.01.016. Epub 2019 Jan 30.

PMID:
30710752
9.

The expanding roles of long non-coding RNAs in the regulation of cancer stem cells.

Ma Z, Wang YY, Xin HW, Wang L, Arfuso F, Dharmarajan A, Kumar AP, Wang H, Tang FR, Warrier S, Tergaonkar V, Sethi G.

Int J Biochem Cell Biol. 2019 Mar;108:17-20. doi: 10.1016/j.biocel.2019.01.003. Epub 2019 Jan 7.

PMID:
30630112
10.

Stemness, Pluripotentiality, and Wnt Antagonism: sFRP4, a Wnt antagonist Mediates Pluripotency and Stemness in Glioblastoma.

Bhuvanalakshmi G, Gamit N, Patil M, Arfuso F, Sethi G, Dharmarajan A, Kumar AP, Warrier S.

Cancers (Basel). 2018 Dec 27;11(1). pii: E25. doi: 10.3390/cancers11010025.

11.

Thymoquinone Inhibits Bone Metastasis of Breast Cancer Cells Through Abrogation of the CXCR4 Signaling Axis.

Shanmugam MK, Ahn KS, Hsu A, Woo CC, Yuan Y, Tan KHB, Chinnathambi A, Alahmadi TA, Alharbi SA, Koh APF, Arfuso F, Huang RY, Lim LHK, Sethi G, Kumar AP.

Front Pharmacol. 2018 Dec 4;9:1294. doi: 10.3389/fphar.2018.01294. eCollection 2018.

12.

Pharmacological Utilization of Bergamottin, Derived from Grapefruits, in Cancer Prevention and Therapy.

Ko JH, Arfuso F, Sethi G, Ahn KS.

Int J Mol Sci. 2018 Dec 14;19(12). pii: E4048. doi: 10.3390/ijms19124048. Review.

13.

Growth hormone during in vitro fertilization in older women modulates the density of receptors in granulosa cells, with improved pregnancy outcomes.

Regan SLP, Knight PG, Yovich JL, Arfuso F, Dharmarajan A.

Fertil Steril. 2018 Dec;110(7):1298-1310. doi: 10.1016/j.fertnstert.2018.08.018.

PMID:
30503129
14.

Dysregulation of Nrf2 in Hepatocellular Carcinoma: Role in Cancer Progression and Chemoresistance.

Raghunath A, Sundarraj K, Arfuso F, Sethi G, Perumal E.

Cancers (Basel). 2018 Dec 3;10(12). pii: E481. doi: 10.3390/cancers10120481. Review.

15.

Eudragit®-based microcapsules of probucol with a gut-bacterial processed secondary bile acid.

Mooranian A, Zamani N, Mikov M, Goločorbin-Kon S, Stojanovic G, Arfuso F, Al-Salami H.

Ther Deliv. 2018 Nov;9(11):811-821. doi: 10.4155/tde-2018-0036.

PMID:
30444461
16.

Pharmacological effects of nanoencapsulation of human-based dosing of probucol on ratio of secondary to primary bile acids in gut, during induction and progression of type 1 diabetes.

Mooranian A, Zamani N, Takechi R, Al-Sallami H, Mikov M, Goločorbin-Kon S, Kovacevic B, Arfuso F, Al-Salami H.

Artif Cells Nanomed Biotechnol. 2018;46(sup3):S748-S754. doi: 10.1080/21691401.2018.1511572. Epub 2018 Nov 13.

PMID:
30422681
17.

Potential Anti-Inflammatory and Anti-Cancer Properties of Farnesol.

Jung YY, Hwang ST, Sethi G, Fan L, Arfuso F, Ahn KS.

Molecules. 2018 Oct 31;23(11). pii: E2827. doi: 10.3390/molecules23112827. Review.

18.

Molecular Targets Modulated by Fangchinoline in Tumor Cells and Preclinical Models.

Mérarchi M, Sethi G, Fan L, Mishra S, Arfuso F, Ahn KS.

Molecules. 2018 Oct 5;23(10). pii: E2538. doi: 10.3390/molecules23102538. Review.

PMID:
30301146
Free PMC Article
19.

TIPE Family of Proteins and Its Implications in Different Chronic Diseases.

Bordoloi D, Banik K, Shabnam B, Padmavathi G, Monisha J, Arfuso F, Dharmarajan A, Mao X, Lim LHK, Wang L, Fan L, Hui KM, Kumar AP, Sethi G, Kunnumakkara AB.

Int J Mol Sci. 2018 Sep 29;19(10). pii: E2974. doi: 10.3390/ijms19102974. Review.

20.

Novel nano-encapsulation of probucol in microgels: scanning electron micrograph characterizations, buoyancy profiling, and antioxidant assay analyses.

Mooranian A, Zamani N, Mikov M, Goločorbin-Kon S, Stojanovic G, Arfuso F, Al-Salami H.

Artif Cells Nanomed Biotechnol. 2018;46(sup3):S741-S747. doi: 10.1080/21691401.2018.1511571. Epub 2018 Sep 27.

PMID:
30260253

Supplemental Content

Loading ...
Support Center